Inactive Instrument

Highlights Concordia International Corp Nasdaq

Equities

CA20653P1027

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

ADVANZ PHARMA Corp. Limited signed an agreement to acquire Global rights of Androcur.	11-06	CI
ADVANZ PHARMA Corp. Limited completed the acquisition of Global rights of Tostran from Kyowa Kirin Co., Ltd..	23-10-17	CI
Alvotech and Advanz Pharma Extend Strategic Partnership to Commercialize Five Proposed Biosimilars in Europe	23-05-24	CI
ADVANZ PHARMA Corp. Limited signed an agreement to acquire Global rights of Tostran from Kyowa Kirin Co., Ltd..	23-04-24	CI
Applied Therapeutics, Inc. Announces Partnership with Advanz Pharma for Commercialization of AT-007 in Europe	23-01-04	CI
ADVANZ PHARMA Corp. Limited acquired Portfolio Of Generic Drugs Of Sanofi.	22-10-02	CI
ADVANZ PHARMA : Nordic Capital Completes US$846 Million Acquisition of Advanz Pharma	21-06-01	MT
Nordic Capital completed the acquisition of ADVANZ PHARMA Corp. Limited (OTCPK:CXRX.F) from a group of shareholders.	21-05-31	CI
ADVANZ PHARMA Corp. Limited Announces Earnings Results for the First Quarter Ended March 31, 2021	21-05-14	CI
Advanz Pharma Corp. Limited Reports Earnings Results for the Full Year Ended December 31, 2020	21-03-17	CI
ADVANZ PHARMA Corp. Limited (OTCPK:CXRX.F) acquired Global Rights to Cyclophosphomide from Zenex Pharmaceuticals Pty Ltd for AUD 0.01 million.	21-01-28	CI
Nordic Capital entered into a scheme of agreement to acquire ADVANZ PHARMA Corp. Limited (OTCPK:CXRX.F) from a group of shareholders for approximately $870 million.	21-01-26	CI
Advanz Pharma Corp. Limited Reports Earnings Results for the Third Quarter Ended September 30, 2020	20-11-06	CI
ADVANZ PHARMA Provides Earnings Guidance for the Fourth Quarter of 2020	20-11-06	CI
ADVANZ PHARMA : Earnings Flash (CXRXF) ADVANZ PHARMA Posts Q3 Revenue $128.7M	20-11-06	MT
ADVANZ PHARMA Corp Receives Preliminary Approaches from Parties	20-10-26	CI
Advanz Pharma Corp. Limited Reports Earnings Results for the Second Quarter Ended June 30, 2020	20-08-12	CI
ADVANZ PHARMA to Seek Acquisitions	20-08-12	CI
ADVANZ PHARMA Corp. Limited Provides Earnings Guidance for the Third Quarter of 2020	20-08-12	CI
Advanz Pharma Corp. Limited Reports Earnings Results for the First Quarter Ended March 31, 2020	20-05-13	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Concordia International Corp Nasdaq

Equities

CA20653P1027

Highlights

Filters